510 related articles for article (PubMed ID: 17218986)
1. Malonyl CoA control of fatty acid oxidation in the newborn heart in response to increased fatty acid supply.
Onay-Besikci A; Sambandam N
Can J Physiol Pharmacol; 2006 Nov; 84(11):1215-22. PubMed ID: 17218986
[TBL] [Abstract][Full Text] [Related]
2. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity.
Folmes CD; Lopaschuk GD
Cardiovasc Res; 2007 Jan; 73(2):278-87. PubMed ID: 17126822
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats.
Assifi MM; Suchankova G; Constant S; Prentki M; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E794-800. PubMed ID: 15956049
[TBL] [Abstract][Full Text] [Related]
4. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
5. LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle.
Thomson DM; Brown JD; Fillmore N; Condon BM; Kim HJ; Barrow JR; Winder WW
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1572-9. PubMed ID: 17925454
[TBL] [Abstract][Full Text] [Related]
6. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
7. Prolonged exposure to palmitate impairs fatty acid oxidation despite activation of AMP-activated protein kinase in skeletal muscle cells.
Pimenta AS; Gaidhu MP; Habib S; So M; Fediuc S; Mirpourian M; Musheev M; Curi R; Ceddia RB
J Cell Physiol; 2008 Nov; 217(2):478-85. PubMed ID: 18561258
[TBL] [Abstract][Full Text] [Related]
8. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects.
Bandyopadhyay GK; Yu JG; Ofrecio J; Olefsky JM
Diabetes; 2006 Aug; 55(8):2277-85. PubMed ID: 16873691
[TBL] [Abstract][Full Text] [Related]
9. Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart.
Yatscoff MA; Jaswal JS; Grant MR; Greenwood R; Lukat T; Beker DL; Rebeyka IM; Lopaschuk GD
Pediatr Res; 2008 Dec; 64(6):643-7. PubMed ID: 18614968
[TBL] [Abstract][Full Text] [Related]
10. Hyperthyroidism facilitates cardiac fatty acid oxidation through altered regulation of cardiac carnitine palmitoyltransferase: studies in vivo and with cardiac myocytes.
Sugden MC; Priestman DA; Orfali KA; Holness MJ
Horm Metab Res; 1999 May; 31(5):300-6. PubMed ID: 10422724
[TBL] [Abstract][Full Text] [Related]
11. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.
Kudo N; Barr AJ; Barr RL; Desai S; Lopaschuk GD
J Biol Chem; 1995 Jul; 270(29):17513-20. PubMed ID: 7615556
[TBL] [Abstract][Full Text] [Related]
12. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart.
Sakamoto J; Barr RL; Kavanagh KM; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1196-204. PubMed ID: 10749714
[TBL] [Abstract][Full Text] [Related]
13. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels.
Hall JL; Lopaschuk GD; Barr A; Bringas J; Pizzurro RD; Stanley WC
Cardiovasc Res; 1996 Nov; 32(5):879-85. PubMed ID: 8944819
[TBL] [Abstract][Full Text] [Related]
14. Acetyl-CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart.
Lopaschuk GD; Witters LA; Itoi T; Barr R; Barr A
J Biol Chem; 1994 Oct; 269(41):25871-8. PubMed ID: 7929291
[TBL] [Abstract][Full Text] [Related]
15. Impact of protein restriction on the regulation of cardiac carnitine palmitoyltransferase by malonyl-CoA.
Holness MJ; Priestman DA; Sugden MC
J Mol Cell Cardiol; 1998 Jul; 30(7):1381-90. PubMed ID: 9710806
[TBL] [Abstract][Full Text] [Related]
16. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation.
Zhou L; Huang H; Yuan CL; Keung W; Lopaschuk GD; Stanley WC
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H954-60. PubMed ID: 18083904
[TBL] [Abstract][Full Text] [Related]
17. Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart.
Saddik M; Gamble J; Witters LA; Lopaschuk GD
J Biol Chem; 1993 Dec; 268(34):25836-45. PubMed ID: 7902355
[TBL] [Abstract][Full Text] [Related]
18. Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat.
Sharma V; Dhillon P; Wambolt R; Parsons H; Brownsey R; Allard MF; McNeill JH
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1609-20. PubMed ID: 18203848
[TBL] [Abstract][Full Text] [Related]
19. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
Lane MD; Wolfgang M; Cha SH; Dai Y
Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
[TBL] [Abstract][Full Text] [Related]
20. The malonyl CoA axis as a potential target for treating ischaemic heart disease.
Ussher JR; Lopaschuk GD
Cardiovasc Res; 2008 Jul; 79(2):259-68. PubMed ID: 18499682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
